These signaling molecules enable crosstalk between CAAs and other cell types in the TME, such as PSCs, tumor-associated neutrophils (TANs), Tregs, and CD8+ T cells, to fuel immunosuppression as well.246,330 Therefore, targeting CAAs has now been deemed a therapeutic strategy against PC. The gene discussed is CD8A; the disease is pachyonychia congenita.